Lifen Zhou

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial

Stanley Cohen, Robin K. Dore, Nancy E. Lane et al. · Arthritis & Rheumatism · 2008 · 570 citations

Medicine, Pharmacology, Pharmacotherapy +17

Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens.

Charles W. Slemenda, Christopher Longcope, Lifen Zhou et al. · Journal of Clinical Investigation · 1997 · 455 citations · Full text

Medicine, Endocrinology, Geriatric Medicine +17

Reduced Rates of Skeletal Remodeling Are Associated with Increased Bone Mineral Density During the Development of Peak Skeletal Mass

Charles W. Slemenda, Munro Peacock, Siu Hui et al. · Journal of Bone and Mineral Research · 1997 · 212 citations · Full text

Medicine, Nutritional Sciences, Pediatrics +17

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

Robin K. Dore, Stanley Cohen, Nancy E. Lane et al. · Annals of the Rheumatic Diseases · 2009 · 194 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention

Messoud Ashina, David Doležil, Jo Bonner et al. · Cephalalgia · 2020 · 171 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15